Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,759,750
Closed -$20.8M 478
2024
Q4
$20.8M Buy
1,759,750
+1,591,750
+947% +$19.7M 0.52% 27
2024
Q3
$2.05M Buy
+168,000
New +$1.39M 0.05% 169
2023
Q3
Sell
-464,298
Closed -$6.23M 635
2023
Q2
$6.23M Buy
464,298
+222,934
+92% +$2.2M 0.13% 92
2023
Q1
$2.68M Buy
+241,364
New +$2.33M 0.06% 225
2022
Q2
Sell
-175,142
Closed -$4.83M 1011
2022
Q1
$4.83M Sell
175,142
-14,194
-7% -$504K 0.05% 304
2021
Q4
$9.53M Sell
189,336
-30,664
-14% -$1.38M 0.09% 89
2021
Q3
$7.82M Buy
+220,000
New +$8.73M 0.06% 141
2021
Q2
Sell
-168,553
Closed -$6.15M 932
2021
Q1
$6.15M Buy
168,553
+82,525
+96% +$3.43M 0.09% 158
2020
Q4
$3.69M Buy
+86,028
New +$3.16M 0.08% 288

Other funds holding XPEV

UBS O'Connor's XPEV Position: Q1 2025 in Review

UBS O'Connor sold out of XPeng (XPEV) in Q1 2025, closing a stake of 1,759,750 shares — an estimated $20.8M sold.

UBS O'Connor first reported a position in XPEV in Q4 2020 and held it in 9 quarters. The position peaked at $20.8M in Q4 2024. 207 funds tracked by Wall St. Rank hold XPEV as of Q1 2025.

  • UBS O'Connor reported no remaining XPeng position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 1,759,750 XPeng shares in Q1 2025, an estimated $20.8M.
  • UBS O'Connor first reported a position in XPeng in Q4 2020 and held it in 9 quarters.
  • UBS O'Connor's XPeng position peaked at $20.8M in Q4 2024.
  • 207 funds tracked by Wall St. Rank held XPeng as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.